Literature DB >> 10570081

GLUT1 and TGF-beta: the link between hyperglycaemia and diabetic nephropathy.

A Mogyorósi1, F N Ziyadeh.   

Abstract

Recent experimental work implicates transforming growth factor-beta (TGF-beta) as an aetiologic mediator of diabetic nephropathy and the ubiquitous glucose transporter GLUT1 as an important permissive factor for the tissue injury caused by hyperglycaemia. High ambient glucose increases GLUT1 expression and glucose transport activity when compared with physiologic glucose concentrations. Treatment of rat mesangial cells with TGF-beta up-regulates GLUT1 mRNA and protein levels and significantly increases glucose uptake. Addition of neutralizing anti-TGF-beta antibody prevents the stimulatory effects of high glucose on GLUT1 expression. Cultured rat mesangial cells transduced with the human GLUT1 gene and thus overexpressing the GLUT1 protein show marked increase in glucose uptake and the synthesis of extracellular matrix molecules, even when grown in normal ambient glucose concentrations. Thus, TGF-beta and GLUT1, two proteins that are up-regulated in glomerular mesangial cells in a hyperglycaemic milieu, can influence the expression of one another. It is therefore fair to conclude that, with successful interruption of the TGF-beta-GLUT1 axis, the beneficial effects of strict glucose control on the development of diabetic nephropathy could likely be augmented.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10570081     DOI: 10.1093/ndt/14.12.2827

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  7 in total

1.  GLUT1 enhances mTOR activity independently of TSC2 and AMPK.

Authors:  Carolyn L Buller; Charles W Heilig; Frank C Brosius
Journal:  Am J Physiol Renal Physiol       Date:  2011-05-25

2.  Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis.

Authors:  Elias Zintzaras; Ioannis Stefanidis
Journal:  J Hum Genet       Date:  2005-01-29       Impact factor: 3.172

Review 3.  Gene expression in diabetic nephropathy.

Authors:  Daniela Hohenadel; Fokko J van der Woude
Journal:  Curr Diab Rep       Date:  2004-12       Impact factor: 4.810

4.  Towards microRNA-based therapeutics for diabetic nephropathy.

Authors:  M L Alvarez; J K DiStefano
Journal:  Diabetologia       Date:  2012-11-08       Impact factor: 10.122

5.  Gene ontology enrichment analysis of α-amylase inhibitors from Duranta repens in diabetes mellitus.

Authors:  Pukar Khanal; B M Patil
Journal:  J Diabetes Metab Disord       Date:  2020-06-07

6.  HIF-1 Mediates Renal Fibrosis in OVE26 Type 1 Diabetic Mice.

Authors:  Bijaya K Nayak; Karthigayan Shanmugasundaram; William E Friedrichs; Rita C Cavaglierii; Mandakini Patel; Jeffrey Barnes; Karen Block
Journal:  Diabetes       Date:  2016-02-23       Impact factor: 9.461

7.  The contribution of genetic variants of SLC2A1 gene in T2DM and T2DM-nephropathy: association study and meta-analysis.

Authors:  I Stefanidis; M Tziastoudi; E E Tsironi; E Dardiotis; S V Tachmitzi; A Fotiadou; G Pissas; K Kytoudis; M Sounidaki; G Ampatzis; P R Mertens; V Liakopoulos; T Eleftheriadis; G M Hadjigeorgiou; M Santos; E Zintzaras
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.